Evid Invest
Who owns MLTXWhat MLTX owns — n/a

Who owns MoonLake Immunotherapeutics?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of MLTX from SEC Form 13F filings across 169 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 169 institutions disclosed 72.7M shares of MoonLake Immunotherapeutics worth $850.1M — about 85.1% of shares outstanding; the largest disclosed holder is BVF INC/IL. Source: SEC Form 13F filings, parsed by EvidInvest.

169

13F holders

$850.1M

value, 2026 filers

85.1%

of shares outstanding (72.7M sh)

34

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of MLTX's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1BVF INC/IL16.0M$187.2M6.2%18.7%0.0%
2Deep Track Capital, LP8.1M$94.8M1.5%9.5%+15.8%
3T. Rowe Price Investment Management, Inc.5.2M$61.1M0.0%6.1%+21.9%
4D. E. Shaw & Co., Inc.3.5M$40.8M0.0%4.1%+3.6%
5Cormorant Asset Management, LP2.9M$33.4M2.2%3.3%-10.9%
6Weiss Asset Management LP2.3M$27.4M0.3%2.7%-9.3%
7TWO SIGMA INVESTMENTS, LP2.0M$23.1M0.0%2.3%+15.2%
8JPMORGAN CHASE & CO1.9M$21.7M0.0%2.2%+36.4%
9Qube Research & Technologies Ltd1.8M$21.0M0.0%2.1%+262.0%
10RENAISSANCE TECHNOLOGIES LLC1.7M$20.1M0.0%2%+167.0%
11CITADEL ADVISORS LLC1.7M$20.0M0.0%2%-13.5%
12Trails Edge Capital Partners, LP1.7M$19.7M2.8%2%+124.0%
13MILLENNIUM MANAGEMENT LLC1.5M$18.0M0.0%1.8%+141.2%
14Logos Global Management LP1.5M$17.6M0.9%1.8%-43.9%
15Vivo Capital, LLC1.4M$16.4M1.8%1.6%0.0%
16BlackRock, Inc.1.4M$16.1M0.0%1.6%+26.0%
17MORGAN STANLEY1.0M$11.9M0.0%1.2%+80.7%
18GREAT POINT PARTNERS LLC855,813$10.0M2.4%1%0.0%
19RICE HALL JAMES & ASSOCIATES, LLC839,945$9.8M0.5%1%+357.0%
20ALGERT GLOBAL LLC762,031$8.9M0.1%0.9%+96.9%
21HRT FINANCIAL LP760,962$8.9M0.0%0.9%+12.0%
22GOLDMAN SACHS GROUP INC708,942$8.3M0.0%0.8%+447.7%
23BANK OF AMERICA CORP /DE/707,846$8.3M0.0%0.8%-5.9%
24ARROWSTREET CAPITAL, LIMITED PARTNERSHIP703,390$8.2M0.0%0.8%-6.3%
25Trexquant Investment LP637,362$7.5M0.0%0.7%+68.6%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.